Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-18

Clinical Trial Update: Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, crossover trial evaluating colchicine in patients with Behcet's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Behcet's Syndrome | Phase 2 | Status: COMPLETED